[Effect of heat-sensitive moxibustion at "Feishu" (BL13) on immunoinflammatory response in allergic rhinitis rats based on PI3K/AKT signaling pathway].

Yicheng Li, Jun Xiong, Meng Lin, Han Hu, Lijun Yao
{"title":"[Effect of heat-sensitive moxibustion at \"Feishu\" (BL13) on immunoinflammatory response in allergic rhinitis rats based on PI3K/AKT signaling pathway].","authors":"Yicheng Li, Jun Xiong, Meng Lin, Han Hu, Lijun Yao","doi":"10.13703/j.0255-2930.20240517-k0004","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To observe the effect of heat-sensitive moxibustion at \"Feishu\" (BL13) on immunoinflammatory response in rats with allergic rhinitis (AR) based on phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway, so as to explore its underlying mechanism.</p><p><strong>Methods: </strong>Thirty-two male SD rats were randomly divided into a blank group (6 rats) and a modeling group (26 rats). In the modeling group, AR model was prepared using systemic and local attack sensitization method with ovalbumin. The successfully-modeled rats were randomized into a model group (6 rats), a medication group (6 rats) and a moxibustion group (14 rats). In the moxibustion group, the suspending moxibustion was operated at bilateral \"Feishu\" (BL13), 40 min each time, once daily, for 21 consecutive days; during which, the temperature of the body and tail was recorded. During intervention, if the temperature of the body and tail increased by >1 ℃, the heat-sensitive reaction at the point was determined in the rats of the moxibustion group, and these rats were collected in a heat-sensitive moxibustion group (8 rats involved and 6 rats of them were randomly collected to ensure the sample-size consistency); and those without heat-sensitive moxibustion reaction were assigned to a traditional moxibustion group (6 rats). In the medication group, fluticasone propionate nasal spray was applied, 8 μL on each side, once daily and for 21 days. The behavioral score for AR symptoms after modeling and intervention, and the content of serum immunoglobulin E (IgE) after modeling were observed. After intervention, the histological morphology of the nasal mucosa was observed using HE staining, the positive expression of thymic stromal lymphopoietin (TSLP) in the nasal mucosa was detected using immunohistochemistry, the levels of IgE, interleukin (IL)-4, IL-5, IL-13 and interferon-γ (IFN-γ) were detected by ELISA, and the protein expression of the member 4 of tumor necrosis factor receptor superfamily (OX40), phosphorylated protein kinase B (p-AKT), phosphorylated phosphatidylinositol 3-kinase (p-PI3K) in nasal mucosa was detected by Western blotting.</p><p><strong>Results: </strong>After modeling, the behavioral score of AR symptoms and serum IgE level in the modeling group were higher than those of the blank group (<i>P</i><0.01), suggesting the success of AR modeling. After intervention, compared with the blank group, the behavioral score of AR symptoms was increased (<i>P</i><0.01);the nasal mucosa structure was disordered, the inflammatory infiltration was severe; the positive expression of TSLP in the nasal mucosa increased (<i>P</i><0.01), the levels of serum IgE, IL-4, IL-5, and IL-13 elevated (<i>P</i><0.01), and the level of IFN-γ decreased (<i>P</i><0.01); and the protein expression of OX40, p-AKT, and p-PI3K in the nasal mucosa increased (<i>P</i><0.05) in the model group. Compared with the model group, the behavioral score of AR symptoms was reduced (<i>P</i><0.01); the nasal mucosa structure, inflammatory infiltration, and vascular dilation were ameliorated to varying degrees; the positive expression of TSLP in the nasal mucosa decreased (<i>P</i><0.01); the content of serum IgE, IL-4, IL-5, and IL-13 decreased (<i>P</i><0.05), and that of IFN-γ increased (<i>P</i><0.05) in the medication, traditional moxibustion, and heat-sensitive moxibustion groups. Compared with the model group, the protein expression of p-AKT was reduced in the medication and traditional moxibustion groups (<i>P</i><0.05), the protein expression of OX40, p-AKT, and p-PI3K in the nasal mucosa decreased in the heat-sensitive moxibustion group (<i>P</i><0.05). When compared with the medication group, the positive expression of TSLP in the nasal mucosa was reduced (<i>P</i><0.05) in the heat-sensitive moxibustion group. In comparison with the traditional moxibustion group, the content of serum IL-13 was reduced and the content of IFN-γ elevated in the heat-sensitive moxibustion and the medication groups (<i>P</i><0.05), the protein expression of p-PI3K reduced in the medication group (<i>P</i><0.05), and the positive expression of TSLP and the protein expression of OX40 and p-PI3K in the nasal mucosa were reduced in the heat-sensitive moxibustion group (<i>P</i><0.05).</p><p><strong>Conclusion: </strong>Heat-sensitive moxibustion at \"Feishu\" (BL13) can alleviate the symptoms of AR rats, ameliorate the inflammatory infiltration and telangiectasia of nasal mucosa, and inhibit immunoinflammatory response, which may be obtained by regulating PI3K/AKT signal pathway.</p>","PeriodicalId":69903,"journal":{"name":"中国针灸","volume":"45 7","pages":"957-966"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国针灸","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.13703/j.0255-2930.20240517-k0004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To observe the effect of heat-sensitive moxibustion at "Feishu" (BL13) on immunoinflammatory response in rats with allergic rhinitis (AR) based on phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway, so as to explore its underlying mechanism.

Methods: Thirty-two male SD rats were randomly divided into a blank group (6 rats) and a modeling group (26 rats). In the modeling group, AR model was prepared using systemic and local attack sensitization method with ovalbumin. The successfully-modeled rats were randomized into a model group (6 rats), a medication group (6 rats) and a moxibustion group (14 rats). In the moxibustion group, the suspending moxibustion was operated at bilateral "Feishu" (BL13), 40 min each time, once daily, for 21 consecutive days; during which, the temperature of the body and tail was recorded. During intervention, if the temperature of the body and tail increased by >1 ℃, the heat-sensitive reaction at the point was determined in the rats of the moxibustion group, and these rats were collected in a heat-sensitive moxibustion group (8 rats involved and 6 rats of them were randomly collected to ensure the sample-size consistency); and those without heat-sensitive moxibustion reaction were assigned to a traditional moxibustion group (6 rats). In the medication group, fluticasone propionate nasal spray was applied, 8 μL on each side, once daily and for 21 days. The behavioral score for AR symptoms after modeling and intervention, and the content of serum immunoglobulin E (IgE) after modeling were observed. After intervention, the histological morphology of the nasal mucosa was observed using HE staining, the positive expression of thymic stromal lymphopoietin (TSLP) in the nasal mucosa was detected using immunohistochemistry, the levels of IgE, interleukin (IL)-4, IL-5, IL-13 and interferon-γ (IFN-γ) were detected by ELISA, and the protein expression of the member 4 of tumor necrosis factor receptor superfamily (OX40), phosphorylated protein kinase B (p-AKT), phosphorylated phosphatidylinositol 3-kinase (p-PI3K) in nasal mucosa was detected by Western blotting.

Results: After modeling, the behavioral score of AR symptoms and serum IgE level in the modeling group were higher than those of the blank group (P<0.01), suggesting the success of AR modeling. After intervention, compared with the blank group, the behavioral score of AR symptoms was increased (P<0.01);the nasal mucosa structure was disordered, the inflammatory infiltration was severe; the positive expression of TSLP in the nasal mucosa increased (P<0.01), the levels of serum IgE, IL-4, IL-5, and IL-13 elevated (P<0.01), and the level of IFN-γ decreased (P<0.01); and the protein expression of OX40, p-AKT, and p-PI3K in the nasal mucosa increased (P<0.05) in the model group. Compared with the model group, the behavioral score of AR symptoms was reduced (P<0.01); the nasal mucosa structure, inflammatory infiltration, and vascular dilation were ameliorated to varying degrees; the positive expression of TSLP in the nasal mucosa decreased (P<0.01); the content of serum IgE, IL-4, IL-5, and IL-13 decreased (P<0.05), and that of IFN-γ increased (P<0.05) in the medication, traditional moxibustion, and heat-sensitive moxibustion groups. Compared with the model group, the protein expression of p-AKT was reduced in the medication and traditional moxibustion groups (P<0.05), the protein expression of OX40, p-AKT, and p-PI3K in the nasal mucosa decreased in the heat-sensitive moxibustion group (P<0.05). When compared with the medication group, the positive expression of TSLP in the nasal mucosa was reduced (P<0.05) in the heat-sensitive moxibustion group. In comparison with the traditional moxibustion group, the content of serum IL-13 was reduced and the content of IFN-γ elevated in the heat-sensitive moxibustion and the medication groups (P<0.05), the protein expression of p-PI3K reduced in the medication group (P<0.05), and the positive expression of TSLP and the protein expression of OX40 and p-PI3K in the nasal mucosa were reduced in the heat-sensitive moxibustion group (P<0.05).

Conclusion: Heat-sensitive moxibustion at "Feishu" (BL13) can alleviate the symptoms of AR rats, ameliorate the inflammatory infiltration and telangiectasia of nasal mucosa, and inhibit immunoinflammatory response, which may be obtained by regulating PI3K/AKT signal pathway.

[基于PI3K/AKT信号通路的热敏灸肺俞(BL13)对变应性鼻炎大鼠免疫炎症反应的影响]。
目的:观察热敏灸“肺俞”(BL13)基于磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B (AKT)信号通路对变应性鼻炎(AR)大鼠免疫炎症反应的影响,并探讨其机制。方法:32只雄性SD大鼠随机分为空白组(6只)和造模组(26只)。造模组采用卵清蛋白全身和局部攻击致敏法制备AR模型。将造模成功的大鼠随机分为造模组(6只)、给药组(6只)和艾灸组(14只)。艾灸组在双侧“肺俞”(BL13)处悬灸,每次40 min,每日1次,连续21天;在此期间,记录了身体和尾巴的温度。干预过程中,若体尾温度升高bbbb1℃,测定艾灸组大鼠在穴位处的热敏反应,并将这些大鼠收集为热敏艾灸组(共8只大鼠,为保证样本量的一致性,随机抽取6只大鼠);无热敏性艾灸反应者设传统艾灸组(6只)。用药组给予丙酸氟替卡松鼻喷雾剂,每侧8 μL,每日1次,连用21 d。观察造模和干预后AR症状行为评分及造模后血清免疫球蛋白E (IgE)含量。干预后,HE染色观察鼻黏膜组织学形态,免疫组化检测鼻黏膜胸腺基质淋巴生成素(TSLP)阳性表达,ELISA检测IgE、白细胞介素(IL)-4、IL-5、IL-13、干扰素-γ (IFN-γ)水平,检测肿瘤坏死因子受体超家族成员4 (OX40)、磷酸化蛋白激酶B (p-AKT)、Western blot检测鼻黏膜磷酸化磷脂酰肌醇3-激酶(p-PI3K)的表达。结果:造模后,造模组AR症状行为评分及血清IgE水平均高于空白组(ppppppppppppppppppppppppp)。结论:热敏灸“肺舒”(BL13)可减轻AR大鼠症状,改善鼻黏膜炎症浸润及毛细血管扩张,抑制免疫炎症反应,其机制可能与调节PI3K/AKT信号通路有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
18644
期刊介绍: Chinese Acupuncture and Moxibustion (founded in 1981, monthly) is an authoritative academic journal of acupuncture and moxibustion under the supervision of China Association for Science and Technology and co-sponsored by Chinese Acupuncture and Moxibustion Society and Institute of Acupuncture and Moxibustion of China Academy of Traditional Chinese Medicine. It is recognised as a core journal of Chinese science and technology, a core journal of Chinese language, and is included in the core journals of China Science Citation Database, as well as being included in MEDLINE and other international well-known medical index databases. The journal adheres to the tenet of ‘improving, taking into account the popularity, colourful and realistic’, and provides valuable learning and communication opportunities for the majority of acupuncture and moxibustion clinical and scientific research workers, and plays an important role in the domestic and international publicity and promotion of acupuncture and moxibustion disciplines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信